Related Experiment Video

Updated: Aug 4, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Tissue-specific promoters in gene therapy for the treatment of prostate cancer

T Shirakawa1, A Gotoh, Y Wada

  • 1Department of Urology, Kobe University School of Medicine, Kobe, Japan. toshiro@kobe-u.ac.jp

Molecular Urology
|May 15, 2002
PubMed

Insights

This study shows prostate cancer-specific promoters can target toxic gene therapy to tumors, reducing harm to normal cells. A Phase I trial is underway for bone metastases using this approach.

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • Virus-mediated gene delivery can harm normal cells.
  • Tissue-specific promoters offer targeted therapeutic gene expression.
  • Prostate cancer presents challenges for localized treatment.

Purpose of the Study:

  • To evaluate prostate cancer-specific promoters for targeted toxic gene therapy.
  • To assess promoter activity in different prostate cancer cell types.
  • To introduce a Phase I clinical trial for osteocalcin promoter-based therapy.

Main Methods:

  • Utilized long PSA and osteocalcin promoters.
  • Tested promoter activity in androgen-dependent and independent prostate cancer cells.
  • Initiated a Phase I clinical trial for bone metastases.

Main Results:

  • Both long PSA and osteocalcin promoters showed high activity in prostate cancer cells.
  • Demonstrated utility for tissue-specific toxic gene therapy.
  • Confirmed promoter activity across different cancer cell dependencies.

Conclusions:

  • Prostate cancer-specific promoters are effective for targeted toxic gene therapy.
  • Osteocalcin promoter shows promise for treating bone metastases.
  • Ongoing Phase I trial will further validate this therapeutic strategy.

More Related Videos

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer08:54

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...